<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface</dc:title>
  <dc:creator>NIO, Yoshinori</dc:creator>
  <dc:creator>HIRAHARA, Noriyuki</dc:creator>
  <dc:creator>MINARI, Yoshimitsu</dc:creator>
  <dc:creator>IGUCHI, Chikage</dc:creator>
  <dc:creator>YAMASAWA, Kunihiro</dc:creator>
  <dc:creator>TOGA, Tomoko</dc:creator>
  <dc:creator>TAMURA, Katsuhiro</dc:creator>
  <dc:relation>Anticancer research -- Anticancer res, ISSN 0250-7005, Vol. 20 (5A) , pp. 3293-3299</dc:relation>
  <dc:date>2000</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Article</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>International Institute of Anticancer Research</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>17 ref</dc:format>
  <dc:subject xml:lang="fr">Hémopathie maligne</dc:subject>
  <dc:subject xml:lang="fr">Lymphoprolifératif syndrome</dc:subject>
  <dc:subject xml:lang="fr">Mammalia</dc:subject>
  <dc:subject xml:lang="fr">Rodentia</dc:subject>
  <dc:subject xml:lang="fr">Vertebrata</dc:subject>
  <dc:subject xml:lang="fr">Agent alkylant</dc:subject>
  <dc:subject xml:lang="fr">Animal</dc:subject>
  <dc:subject xml:lang="fr">Anticancéreux</dc:subject>
  <dc:subject xml:lang="fr">Antigène histocompatibilité classe I</dc:subject>
  <dc:subject xml:lang="fr">Chimiothérapie</dc:subject>
  <dc:subject xml:lang="fr">Cisplatine</dc:subject>
  <dc:subject xml:lang="fr">Lignée cellulaire établie</dc:subject>
  <dc:subject xml:lang="fr">Modèle animal</dc:subject>
  <dc:subject xml:lang="fr">Plasmocytome</dc:subject>
  <dc:subject xml:lang="fr">Platine II Complexe</dc:subject>
  <dc:subject xml:lang="fr">Réponse immune</dc:subject>
  <dc:subject xml:lang="fr">Souris</dc:subject>
  <dc:subject xml:lang="fr">Système H-2</dc:subject>
  <dc:subject xml:lang="fr">Système histocompatibilité majeur</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="fr">Lignée MOPC 104E</dc:subject>
  <dc:subject xml:lang="en">Malignant hemopathy</dc:subject>
  <dc:subject xml:lang="en">Lymphoproliferative syndrome</dc:subject>
  <dc:subject xml:lang="en">Mammalia</dc:subject>
  <dc:subject xml:lang="en">Rodentia</dc:subject>
  <dc:subject xml:lang="en">Vertebrata</dc:subject>
  <dc:subject xml:lang="en">Alkylating agent</dc:subject>
  <dc:subject xml:lang="en">Animal</dc:subject>
  <dc:subject xml:lang="en">Antineoplastic agent</dc:subject>
  <dc:subject xml:lang="en">Class I histocompatibility antigen</dc:subject>
  <dc:subject xml:lang="en">Chemotherapy</dc:subject>
  <dc:subject xml:lang="en">Cisplatin</dc:subject>
  <dc:subject xml:lang="en">Established cell line</dc:subject>
  <dc:subject xml:lang="en">Animal model</dc:subject>
  <dc:subject xml:lang="en">Plasmacytoma</dc:subject>
  <dc:subject xml:lang="en">Platinum II Complexes</dc:subject>
  <dc:subject xml:lang="en">Immune response</dc:subject>
  <dc:subject xml:lang="en">Mouse</dc:subject>
  <dc:subject xml:lang="en">H-2-System</dc:subject>
  <dc:subject xml:lang="en">Major histocompatibility system</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="es">Hemopatía maligna</dc:subject>
  <dc:subject xml:lang="es">Linfoproliferativo síndrome</dc:subject>
  <dc:subject xml:lang="es">Mammalia</dc:subject>
  <dc:subject xml:lang="es">Rodentia</dc:subject>
  <dc:subject xml:lang="es">Vertebrata</dc:subject>
  <dc:subject xml:lang="es">Agente alquilante</dc:subject>
  <dc:subject xml:lang="es">Animal</dc:subject>
  <dc:subject xml:lang="es">Anticanceroso</dc:subject>
  <dc:subject xml:lang="es">Antígeno histocompatibilidad clase I</dc:subject>
  <dc:subject xml:lang="es">Quimioterapia</dc:subject>
  <dc:subject xml:lang="es">Cisplatino</dc:subject>
  <dc:subject xml:lang="es">Línea celular establecida</dc:subject>
  <dc:subject xml:lang="es">Modelo animal</dc:subject>
  <dc:subject xml:lang="es">Plasmocitoma</dc:subject>
  <dc:subject xml:lang="es">Platino II Complejo</dc:subject>
  <dc:subject xml:lang="es">Respuesta inmune</dc:subject>
  <dc:subject xml:lang="es">Ratón</dc:subject>
  <dc:subject xml:lang="es">Sistema H-2</dc:subject>
  <dc:subject xml:lang="es">Sistema histocompatibilidad mayor</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject>002B02R02: Chimiothérapie / Chemotherapy</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 1526780</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>